Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 42

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00628394Phase 4Completed
Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation
Cognition in Schizophrenia
Principalinvestigator
NCT00690235Phase 4Completed
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia
DiabetesSchizoaffective DisorderSchizophrenia+1 more
Principalinvestigator
NCT00690274Phase 2Completed
Study to Demonstrate Cognitive Enhancing Effects of BF2.649
Schizophrenia
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of Texas Southwestern Medical Center

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00628394Phase 4PrincipalInvestigator

Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation

Cognition in Schizophrenia
Completed
NCT00690235Phase 4PrincipalInvestigator

Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia

DiabetesSchizoaffective DisorderSchizophrenia+1 more
Completed
NCT00690274Phase 2PrincipalInvestigator

Study to Demonstrate Cognitive Enhancing Effects of BF2.649

Schizophrenia
Completed

All 3 trials loaded